Date: 5/01/2009
Length: 00:19:08
Size: 8.76MB
Thought Leaders: James Featherstone, Ph.D., VP of Product Development and Commercialization for the EU, Quintiles Consulting, Bruce E. Johnson, Ph.D., Senior Research Director, Eidetics, a division of Quintiles Consulting, and Heidi Hunter, Global VP, Business Development, Quintiles
In episode two, of a three-part series, "Surviving to Thriving in Stormy Weather," our thought leaders discuss new commercialization processes as healthcare moves towards personalized medicine. They also cover how to assess market potential for personalized therapies, post-launch sales strategies for niche drugs, and finally, meeting the needs of global and regional markets for these types of therapies.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment